Proprietary Culture-Medium Technology (RGMc)
ABin Cell optimizes stem-cell activity through an in-house special culture medium. The technology raises cell survival, maintains stable quality, and boosts exosome output to roughly twice or more of conventional levels.
- In-house special medium optimizes stem-cell activity
- Higher cell survival and stable quality
- Exosome output raised to about 2× or more of conventional levels
- High growth-factor content increases biological activity
Higher CXCR4/CXCR7 Expression = Maximized Homing
Damaged tissue secretes a chemokine called SDF-1, which the CXCR4 and CXCR7 receptors on the stem-cell surface recognize, guiding the cells to the injury (homing). ABin Cell's medium technology markedly raises the expression of these receptors, greatly improving target-tissue arrival and engraftment efficiency.
- Increased expression of SDF-1 receptors (CXCR4/CXCR7)
- Improved ability to sense damaged tissue
- Higher target-tissue arrival and engraftment efficiency
- Maximized homing effect
Maximizing Therapeutic Efficacy
By improving these biological properties, ABin Cell maximizes the therapeutic efficacy of stem-cell treatment — including tissue regeneration and anti-inflammatory effects.
- Enhanced tissue regeneration
- Stronger anti-inflammatory effect
- Improved immunomodulation
- Greater durability of treatment
This content is provided for general informational purposes only, and individual treatment outcomes may vary.